Subscribe to our Newsletters !!

    Kumar Jeetendra

    Dubai to start inoculations with Pfizer-BioNTech vaccine from today

    Dubai will begin inoculating people with the COVID-19 vaccine created by Pfizer and BioNTech for free from Wednesday, the emirate’s government said, linking Saudi Arabia which last week became the first Arab nation to begin using this vaccine. The UAE’s Ministry of Health and Prevention enrolled the Pfizer-BioNTech’s vaccine for emergency use on the request

    COVID-19 immunity lasts at the least eight months, wish for durability of vaccinations: Study

    Individuals who have recovered from the novel coronavirus infection have immune memory to protect against reinfection for eight months, according to a new study which offers powerful evidence for the likelihood that COVID-19 vaccines will operate for extended periods. While earlier studies have demonstrated that antibodies against the coronavirus wane after the first month or

    Approx 1 million americans vaccinated for COVID; Tennessee new epicenter

    Tennessee emerged alongside California on Wednesday as an epicenter of the latest COVID-19 surge even while more than 1 million Americans have been vaccinated as U.S. political leaders sought to guard against an extremely contagious coronavirus variant sweeping across Britain. Tennessee averaged nearly 128 new infections per 100,000 people during the last week, the highest

    Moderna expects its COVID-19 vaccine to shield towards UK coronavirus variant

    Moderna Inc said it anticipates that the immunity induced by its COVID-19 vaccine would be protective against the coronavirus variants reported in britain. The company said it intends to conduct tests to confirm the vaccine’s action against any strain. Moderna’s comments came amid the British government’s plan to put massive swathes of England under its

    Study clarifies the impact of getting old on hematopoietic stem cells

    By shifting mouse elderly hematopoietic stem cells (aged HSCs) to the environment of young mice (bone marrow niche), it was shown that the pattern of stem cell gene expression was rejuvenated to that of young hematopoietic stem cells. On the other hand, the function of elderly HSCs failed to recover in the young bone marrow

    Polygenic threat ratings from multi-populace information should enhance IBD predictions

    Using genetic data from nearly 30,000 individuals, Mount Sinai researchers have assembled hazard scores from a combination of datasets representing distinct ancestral populations that improve prediction of risk for inflammatory bowel diseases (IBD) including Crohn’s disease and ulcerative colitis. The research was published in Gastroenterology on December 24. The researchers found that polygenic risk scores,